Kevin C. Kenny, J.D., LL.M - Chief Executive Officer
Kevin C. Kenny is Chief Executive Officer of Decernis and a co-founder of the Company. He is an experienced regulatory attorney who has worked and consulted for 15 years in the product safety and food arenas. Mr. Kenny advises some of the world’s largest manufacturers in the areas of Food Additives, Food Contact and Food Standards, globally. Mr. Kenny routinely manages regulatory audits to support the global compliance and information needs of Decernis’ clients. The matrix of recommendations that result from such audits helps improve a client’s ability to meet stated compliance goals. Mr. Kenny also meets and coordinates with clients globally to determine the scope of coverage for Decernis content and is knowledgeable about all areas of food and consumer product compliance. In the past decade, he has met with various governmental agencies and organizations in over 40 countries to discuss regulatory compliance and related matters.
Mr. Kenny has lived and worked for eight years in five European and Asian countries, and is fluent in German, French and Spanish. He possesses an honors Juris Doctor, an LL.M. in Public International Law and the Hague Diplôme de Droit International. In 1992, he was awarded an Alexander von Humboldt Research Fellowship in Bonn, Germany, directly followed by two-years as an assistant professor at the Walther Schücking Institute of International Law at Christian-Albrechts-Universität in Kiel, Germany. Mr. Kenny coordinated the development of teaching curricula for each of the courses he taught.
Before Decernis, Mr. Kenny worked as a regulatory attorney at a Bethesda, Maryland-based regulatory content provider, most recently as VP, International Operations. An expert in food, chemicals and plastics regulation with particularly strong expertise and contacts in Asia, Mr. Kenny is a frequent speaker at international conferences and a member on the Regulatory Affairs Committees of several major food, cosmetic and consumer product associations in the U.S. and Europe.
Dr. Ruud Overbeek - Chief of Strategy and Business Development
Dr. Ruud Overbeek is the Chief of Strategy and Business Development of Decernis. Prior to joining Decernis, he most recently served as Vice President of Global Health & Environmental Services and Chemicals & Pharmaceuticals North America for Intertek. At Intertek, Dr. Overbeek directed and delivered solutions enabling customers to ensure safety, quality, and performance of new and existing products. He has been granted over twenty patents and formerly received the DuPont Award for outstanding research.
Prior to joining Intertek, Ruud worked for Avantium Technologies as Vice President of Intellectual Assets & Licensing, Business Development, Operations and Discovery. He started his career in ABB Lummus Global as Technology Development Manager. Ruud is a member of a number of Associations including The Royal Dutch Chemical Society, the Dutch Catalysis Society and was appointed to the Health and Beauty America (HBA) Scientific Advisory Board. Ruud was awarded the DuPont Chemical Company Prize for Outstanding Independent Research and holds a Doctorate in Catalysis and a Master and Bachelors in Chemistry from Utrecht University. He has been granted over twenty patents.
Dr. Chetan Parmar - Chief Financial Officer and Director of European Operations
Dr. Chetan Parmar is the Chief Financial Officer and Director of European Operations at Decernis LLC. In this role, Dr. Parmar will lead the company’s financial management and reporting, and support European market expansion. He was most recently the interim-CEO of Crop Health & Protection (CHAP), a UK Agritech startup business supporting the development of disruptive technologies. Prior to that Dr. Parmar was at Intertek for over 9 years with his most recent role leading Intertek’s global Life Sciences business including pharmaceuticals, health and beauty, materials sciences, and chemical regulatory consulting. During his time with Intertek, Dr. Parmar also held a variety of other senior leadership roles including, amongst others, managing the global food business line and successfully leading and closing 14 acquisitions as part of the Intertek Corporate Development team. He also spent 5 years at Deloitte, with 2 years in the M&A Tax group. Dr. Parmar is a Chartered Accountant (ICAEW) and received his PhD in Chemistry from Imperial College London.
Andrew (Pat) Waldo - former Chief Executive Officer
Andrew (Pat) Waldo is a founder of the Company and was Chief Executive Officer until his retirement in September 2020. Mr. Waldo is a leader in the development of global compliance management solutions for industry. He has worked with industry and governments around the world. Under his management the Company has established operational and sales groups in the U.S., Europe, and Asia.
Decernis is the second company that he has founded. Previously, he was President of Ariel Research Corporation, later acquired by Eastman Chemicals. His work has been nominated for and a finalist of the U.S. Smithsonian Institution-Computerworld award for innovation in the field of Agriculture, Energy, and Environment. He holds a number of patents in the area of information control and supply chain management. In early work he represented industry interests in the development of U.S. chemical control laws. He is the author of several textbooks in this area.